Hazards of Therapy for Excessive Hypertension in Acute Stroke
- 12 January 1980
- journal article
- research article
- Published by Wiley in Acta Medica Scandinavica
- Vol. 207 (1-6) , 253-257
- https://doi.org/10.1111/j.0954-6820.1980.tb09717.x
Abstract
Six cases with acute onset of neurological symptoms and extremely high blood pressure (BP) are reviewed. Hypertensive crisis or stroke were the main differential diagnoses. According to what is advocated for both situations, prompt antihypertensive therapy was instituted. Although recommended doses of hydralazine, reserpine or furosemide were given, the systolic BP fell to < 100 mmHg. Intracerebral hemorrhage or infarction was subsequently established in all patients and only 1 survived. Convincing evidence for a beneficial effect of BP reduction in acute stroke is lacking. Excessive response to therapy was seen in some patients. Moderate lowering of BP might reduce cerebral blood flow in these patients, often chronically hypertensive and with raised intracranial pressure. Extreme caution with antihypertensive therapy seems warranted if the diagnosis of hypertensive crisis is not certain and a stroke is suspected.Keywords
This publication has 10 references indexed in Scilit:
- Hypertension crisis. Recognition and managementJAMA, 1977
- Hypertension CrisisPublished by American Medical Association (AMA) ,1977
- Autoregulation of cerebral blood flow in hypertensive patients. The modifying influence of prolonged antihypertensive treatment on the tolerance to acute, drug-induced hypotension.Circulation, 1976
- Diseases of the central nervous system. Treatment of stroke.BMJ, 1975
- Effect of Antihypertensive Treatment on Stroke RecurrencePublished by American Medical Association (AMA) ,1974
- Reninaktivität im Nierenvenenblut und ihre Stimulierbarkeit durch Hydralazin und TheophyllinKlinische Wochenschrift, 1973
- Effects Morbidity of Treatment on in HypertensionJAMA, 1970
- HYPOTENSIVE THERAPY IN STROKE SURVIVORSThe Lancet, 1970
- Effects of Treatment on Morbidity in HypertensionJAMA, 1967
- A TRIAL OF LONG-TERM HYPOTENSIVE THERAPY IN CEREBROVASCULAR DISEASEThe Lancet, 1964